Every story in this section, newest first — page 270 of 373.
Takeda (NYSE:TAK) and Protagonist Therapeutics (NASDAQ:PTGX) secured a major regulatory milestone on Monday as the U.S. Food and Drug Administration (FDA) granted Priority Review to rusfertide, an investigational treatment for polycythemia vera (PV).
Venture Global (NYSE:VG) and Trafigura announced a new, binding liquefied natural gas (LNG) supply agreement on Monday, marking a strategic shift toward mid-term contracting for the Arlington-based energy producer.
Alaunos Therapeutics (NASDAQ:TCRT) released proof-of-concept data from two separate diet-induced obesity (DIO) mouse studies on Monday, marking a strategic pivot toward non-hormonal metabolic treatments.
Ocugen (NASDAQ:OCGN) announced Monday that it has completed patient enrollment for its pivotal Phase 3 liMeliGhT clinical trial, evaluating OCU400 for the treatment of retinitis pigmentosa (RP).
Pharvaris (NASDAQ:PHVS) dominated the clinical spotlight at the American Academy of Allergy, Asthma & Immunology (AAAAI) 2026 meeting on Monday, unveiling full data from its RAPIDe-3 and CHAPTER-1 trials.
Highway Holdings (NASDAQ:HIHO), a Hong Kong-based manufacturer of precision metal components and provider of contract manufacturing services, on Monday reported financial results for its third quarter and nine-month period ended December 31, 2025.
The Hain Celestial Group (NASDAQ:HAIN) finalized a major structural overhaul on Monday with the completed sale of its North American snacks portfolio to Snackruptors.
StealthGas (NASDAQ:GASS) delivered a strong financial performance for the fourth quarter and full year 2025, reporting a net income of $12.8 million for the final three months of the year.
Sionna Therapeutics (NASDAQ:SION) entered 2026 with a substantial financial cushion, reporting $310.3 million in cash, cash equivalents, and marketable securities as of December 31, 2025.
HBT Financial (NASDAQ:HBT), the holding company for Heartland Bank and Trust Company, announced Monday that it has successfully completed its merger with CNB Bank Shares.
AES (NYSEAES) announced Monday that it has entered into a definitive merger agreement to be taken private by a consortium of heavyweight infrastructure investors.
Uniti Group (NASDAQ:UNIT) reported a fourth-quarter net loss of $305.7 million on Monday, reflecting the heavy financial lifting required to complete its massive merger with Windstream.
Nvidia (NASDAQ:NVDA) moved to secure the future of AI networking on Monday, announcing twin $2 billion investments in photonic product leaders Lumentum Holdings (NASDAQ:LITE) and Coherent (NYSE:COHR).
Turning Point Brands (NYSE:TPB) delivered a strong conclusion to fiscal 2025, reporting fourth-quarter net income of $8.2 million, or 42 cents per share.
Apogee Therapeutics (NASDAQ:APGE) solidified its clinical roadmap for 2026 on Monday, reporting a year-end cash position of $902.9 million.
WhiteHorse Finance (NASDAQ:WHF) reported fourth-quarter net income of $8.4 million on Monday, delivering a performance that cleared analyst hurdles on both the top and bottom lines.
Xeris Biopharma Holdings (NASDAQ:XERS), a Chicago-based specialty pharmaceutical company focused on therapies for rare endocrine and metabolic diseases, on Monday reported net income of $11.1 million for its fourth quarter ended December 31, 2025.
Kaspi.kz (NASDAQ:KSPI) delivered a robust set of fiscal 2025 results, reporting a 19% year-over-year increase in total revenue to KZT 3.1 trillion.
uniQure (NASDAQ:QURE) entered 2026 with a dual narrative of clinical progress and regulatory complexity.
Compugen (NASDAQ:CGEN) delivered a transformative fiscal 2025, reporting a sharp pivot to profitability and a significantly bolstered balance sheet.
ADT ( NYSE:ADT) delivered a robust fiscal 2025 performance, reporting total revenue of $5.13 billion, a 5% increase over the prior year.
Sealed Air (NYSE:SEE), a leading provider of protective packaging solutions, including Bubble Wrap, Cryovac food packaging, and automated systems, on Monday reported fourth-quarter net sales of $1.40 billion for the period ended December 31, 2025.
Venture Global (NYSE:VG) delivered a blockbuster set of financial results for fiscal 2025, cementing its position as a dominant force in the global energy transition.
Norwegian Cruise Line Holdings (NYSE:NCLH) delivered a robust fiscal 2025 performance, reporting record total revenue of $9.8 billion.
